Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.
Group B Streptococcus (GBS) causes substantial morbidity but most individuals exposed to the organism remain healthy. These experiments tested the hypothesis that engagement of the complement receptor 3 (CR3) lectin site would effectively trigger neutrophil-mediated phagocytosis of complement-opsonized type III GBS by nonimmune human sera. Using an opsonophagocytosis assay, saccharides identified as interacting with the CR3 lectin site effectively inhibited neutrophil-mediated killing of type III, strain COH1. Fructose, which does not interact with the lectin site, promoted significantly less inhibition of opsonophagocytosis. Saccharide-mediated inhibition was reversed in a dose-related fashion by addition of type III, GBS capsular polysaccharide-specific immunoglobulin G. When capsule-deficient or asialo mutant type III strains were employed, the lectin site was not required. Structurally defined GBS serotypes with a side chain at least two sugars in length engaged the lectin site, and N-acetyl D-glucosamine was not a required component monosaccharide. Intact type III capsular polysaccharide interacted significantly more efficiently with the lectin site than did oligosaccharides representing approximately 5 or 20 repeating units, respectively. Taken together, these experiments indicate that interaction of type III GBS capsular polysaccharide with the lectin site of CR3 effects phagocytosis of these organisms by nonimmune serum. Use of this mechanism of innate immunity provides a potential explanation for the infrequency with which susceptible individuals exposed to type III GBS develop invasive infection.
Albanyan
E A
EA
Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.
Edwards
M S
MS
D000328:Adult; D000907:Antibodies, Bacterial / Q000276:immunology; D000918:Antibody Specificity; D016667:Bacterial Capsules / Q000737:chemistry / Q000378:metabolism*; D002240:Carbohydrate Sequence; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007231:Infant, Newborn; D037102:Lectins / Q000737:chemistry / Q000378:metabolism*; D016177:Macrophage-1 Antigen / Q000737:chemistry / Q000378:metabolism; D008969:Molecular Sequence Data; D009005:Monosaccharides / Q000737:chemistry; D009895:Opsonin Proteins; D010587:Phagocytosis; D018805:Sepsis / Q000382:microbiology; D012703:Serotyping; D013290:Streptococcal Infections / Q000382:microbiology; D013292:Streptococcus agalactiae / Q000276:immunology* / Q000378:metabolism
D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D037102:Lectins; D016177:Macrophage-1 Antigen; D009005:Monosaccharides; D009895:Opsonin Proteins